NexgenRX Inc. | Income Statement
Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
4,910.50
4,216.40
4,692.00
5,754.70
5,642.20
6,956.60
Cost of Goods Sold (COGS) incl. D&A
943.90
3,611.10
1,056.50
1,186.10
1,249.10
1,448.60
Gross Income
3,966.70
605.30
3,635.50
4,568.60
4,393.10
5,507.90
SG&A Expense
3,462.80
962.50
3,952.70
4,051.70
4,952.30
6,278.40
EBIT
503.90
357.20
-
516.90
559.20
770.40
Unusual Expense
177.30
-
231.20
-
-
-
Interest Expense
72.70
120.40
102.30
104.10
96.00
163.40
Pretax Income
608.50
477.60
188.30
412.80
625.90
721
Income Tax
-
-
-
175.00
-
24.10
Consolidated Net Income
608.50
477.60
188.30
587.80
625.90
696.90
Net Income
608.50
477.60
188.30
587.80
625.90
696.90
Net Income After Extraordinaries
608.50
477.60
188.30
587.80
625.90
696.90
Net Income Available to Common
608.50
477.60
188.30
587.80
625.90
696.90
EPS (Basic)
0.01
0.01
0.00
0.01
0.01
0.01
Basic Shares Outstanding
55,539.00
55,539.00
57,187.70
58,777.60
60,299.50
68,228
EPS (Diluted)
0.01
0.01
0.00
0.01
0.01
0.01
Diluted Shares Outstanding
55,539.40
55,539.00
57,187.70
59,625.20
60,299.50
68,228
EBITDA
567.50
293.20
242.70
592.10
429.30
453.30
Non-Operating Interest Income
-
-
-
-
29.30
212.90
About NexgenRX
View Profile
